In bladder cancer (Wang and Jiang, 2022), patients with high PCAT19 expression have significantly lower survival rates and worse prognosis, with notable differences in tumor size, T staging, tumor grade, lymph node metastasis, and distant metastasis. This evidence concerns the gene PCAT19 and urinary bladder cancer.